Table 1. Characteristics of EAE following anti-TNFR1 treatment from the day of immunization.
Control IgG | Anti-TNFR1 | |
Incidence of EAE | 100% | 100% |
Day of onset | 14.56±0.96 | 17.53±0.63 |
Maximum mean disease score | 2.2±0.26 | 1.32±0.84 |
Cumulative disease score to day 21 | 42±3.79 | 19.9±2.35 |